Fluorine in PDB 7b34: MST3 in Complex with Compound MRIA12

All present enzymatic activity of MST3 in Complex with Compound MRIA12:
2.7.11.1;

The structure of MST3 in Complex with Compound MRIA12, PDB code: 7b34 was solved by R.Tesch, M.Rak, A.C.Joerger, S.Knapp, Structural Genomics Consortium(Sgc), with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	39.73 / 2.10
Space group	C 1 2 1
Cell size a, b, c (Å), α, β, γ (°)	99.262, 59.067, 61.795, 90.00, 93.05, 90.00
R / Rfree (%)	18.9 / 21.5

The structure of MST3 in Complex with Compound MRIA12 also contains other interesting chemical elements:

Chlorine

(Cl)

1 atom

The binding sites of Fluorine atom in the MST3 in Complex with Compound MRIA12 (pdb code 7b34). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the MST3 in Complex with Compound MRIA12, PDB code: 7b34:

Fluorine binding site 1 out of 1 in the MST3 in Complex with Compound MRIA12


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of MST3 in Complex with Compound MRIA12 within 5.0Å range: probe atom residue distance (Å) B Occ A:F608 b:41.3 occ:1.00 F A:SQK608 0.0 41.3 1.0 C12 A:SQK608 1.4 46.3 1.0 C13 A:SQK608 2.4 48.6 1.0 C11 A:SQK608 2.4 39.8 1.0 C10 A:SQK608 2.9 36.7 1.0 CD1 A:LEU86 3.0 47.8 1.0 C9 A:SQK608 3.1 41.7 1.0 CG2 A:ILE109 3.3 39.3 1.0 SD A:MET111 3.6 47.4 1.0 C14 A:SQK608 3.6 44.6 1.0 N3 A:SQK608 3.6 41.3 1.0 CD1 A:TYR97 3.7 50.4 1.0 CG A:MET111 3.8 40.5 1.0 CE1 A:TYR97 3.9 57.3 1.0 C17 A:SQK608 3.9 34.8 1.0 C15 A:SQK608 4.1 45.3 1.0 CE A:MET111 4.2 50.3 1.0 C8 A:SQK608 4.3 43.7 1.0 CG A:LEU86 4.4 47.4 1.0 CB A:ILE109 4.5 37.3 1.0 O A:HOH738 4.8 41.1 1.0 CB A:LEU86 4.9 43.4 1.0 CG A:TYR97 4.9 46.3 1.0 CD1 A:ILE109 4.9 39.8 1.0 C18 A:SQK608 4.9 41.8 1.0

R.Tesch, M.Rak, A.C.Joerger, S.Knapp, Structural Genomics Consortium (Sgc). Structure-Based Design of Selective Salt-Inducible Kinase (Sik) Inhibitors To Be Published.